> > Speaker Biographical Information

Cecelia C. Yates, PhD

Dr. Cecelia Yates is an Assistant Professor, Department of Health Promotion & Development, School of Nursing at the University of Pittsburgh, with a secondary appointment in the Department of Pathology, School of Medicine, and McGowan Institute for Regenerative Medicine. Dr. Yates attended Tuskegee University, Tuskegee, Alabama, where she earned her BS in Biology/Chemistry, and her PhD in Integrative Biomedical Science and Pathology in conjunction with the University of Pittsburgh. Upon completing her education, she participated in a post-doctoral fellowship in Pathology at the University of Pittsburgh’s School of Medicine. Dr. Yates developed the first cellular and molecular pathology laboratory fully equipped for basic, translational, and clinical research located within Pitt’s School of Nursing. As a Principal Investigator, her research interest focuses on fibrosing and chronic wound diseases: specifically, mechanism of tissue repair based on bidirectional interaction among cells and their microenvironment, biomaterials and host interactions, and biobehavioral factors and cellular immunity.

Dr. Yates’ research is supported externally by the National Institute of Nursing Research, National Institute of General Medical Sciences, National Institute of Arthritis and Musculoskeletal and Skin Diseases, and internally by University of Pittsburgh Genomic Hub and Central Research Development Fund. Her entrepreneurial activities include four issued US patents and three pending patents associated with her work. She is also the co-founder and member of the Scientific Advisory Board of a Pittsburgh-based start-up, Ocugenix, focused on ocular therapeutic development with the goal of providing treatment for fibrosis in eye diseases.

Dr. Yates is on the editorial board of The American Journal of Pathology and publication committee. She also is a member of council for the American Society for Investigative Pathology and chairs the Committee for Career Development and Diversity. She actively participates in Pathology Research and Science Policy committee that works in cooperation with FASEB. She has an active interest in policy impact on translational research, human subject protection and biomedical ethics, and advocating for the next generation and early career investigators.